A randomized, controlled trial by researchers in the Netherlands compared 102 subjects with recurrent depression receiving mindfulness-based cognitive therapy (MBCT) + treatment-as-usual (TAU) with 103 receiving TAU alone. Comparisons between persons with and without a current depressive episode found that MBCT is as effective for patients with recurrent depression who are currently depressed as for patients who are in remission. Results are in the May issue of Psychological Medicine.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.